SCISPARC LTD
SPRC · NASDAQ
Updated at 2026-10-13 12:22:21
- Today's High
- --
- Today’s Low
- --
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.47
- Previous Close
- $4.08
- Volume
- 10.8K
- Market Cap
- $2.33M
- P/E Ratio
- --
- EPS
- $-461.24
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- TOWER A, TEL AVIV-YAFO, ISRAEL, 6971916
- Country
- IL
- Listing Date
- 2021-12-22
- Fiscal Year End
- December
- Shares Outstanding
- 570K
- CIK
- 0001611746
- Website
- scisparc.com
SciSparc Ltd., a specialized clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. The company is headquartered in Tel Aviv, Israel.
Financial Metrics
Revenue
2026-06-30
$284K
2026-03-31
$395K
2025-09-30
$461K
2025-03-31
$466K
Operating Expenses
2026-06-30
$5.09M
2026-03-31
-$176K
2025-09-30
$9.32M
2025-03-31
$10.87M
Net Income
2026-06-30
-$5.37M
2026-03-31
-$2.85M
2025-09-30
-$9.32M
2025-03-31
-$2.84M
Net Profit Margin
2026-06-30
-1.89K%
2026-03-31
-721.77%
2025-09-30
-2.02K%
2025-03-31
-609.87%
Earnings Per Share
2026-06-30
--
2026-03-31
--
2025-09-30
--
2025-03-31
$-6.20
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$4.79M
2026-03-31
$447K
2025-09-30
-$8.96M
2025-03-31
-$3.66M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-09-30
--
2025-03-31
0.49%
| Item | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | $284K | $395K | $461K | $466K |
| Operating Expenses | $5.09M | -$176K | $9.32M | $10.87M |
| Net Income | -$5.37M | -$2.85M | -$9.32M | -$2.84M |
| Net Profit Margin | -1.89K% | -721.77% | -2.02K% | -609.87% |
| Earnings Per Share | -- | -- | -- | $-6.20 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$4.79M | $447K | -$8.96M | -$3.66M |
| Effective Tax Rate | -- | -- | -- | 0.49% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.